LAMEA Small Animal Imaging (In-vivo) Market By Component (Micro-MRI, Optical Imaging, Nuclear Imaging), Application (Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies, Epigenetics)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The LAMEA Small Animal Imaging (In-vivo) Market is expected to grow at a CAGR of 14.6% during 2016 -2022. The Optical Imaging market dominated the LAMEA Small Animal Imaging (In-vivo) Market in 2015, and would grow at a CAGR of 11.6% during the forecast period. The Micro-MRI market is expected attain a market size of $48.2 million by 2022. A wide range of small animal imaging (in-vivo) devices are majorly used in wide range of domains, namely cancer cell research, monitoring drug response during drug development, assessing the bio-distribution patterns of new chemical entities, biomarker research in animal models, in longitudinal studies and others. These devices have gained prominence and are majorly being used in epigenetic research studies, receptor targeting, and defining mechanism of action.
The report highlights the adoption of Small Animal Imaging (In-vivo) Market in LAMEA (Latin America, Middle East and Africa) region. Based on the Technology, the LAMEA Small Animal Imaging (In-vivo) Market is segmented into Micro-MRI, Optical Imaging, Nuclear Imaging and Others (Micro-Ultrasound and micro-CT) segment. Based on the Application, the market is bifurcated into Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics segments.
The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. Key players profiled in the report includes Thermo Fisher Scientific Inc., Mediso Medical Imaging Systems, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., Siemens AG and Fujifilm Holdings Corporation.